Stock listing
NASDAQ:DARE Dare Bioscience, Inc. Stock
Home listing (NASDAQ) of Dare Bioscience, Inc.
Follow Dare Bioscience, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:DARE
$0.70 USD +0.02 (+2.7%)
Close on Oct 30, 2026
- Day range
- $0.67 – $0.703 USDOct 30, 2026
- Volume
- 651,427 sharesOct 30, 2026
- Market cap
- $13.76M USDAt the close on Oct 30, 2026 · price × 19.67M shares outstanding
- 52-week range
- $0.625 – $3.78 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $465,663 USDMedian day 155,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DARE · Home | $0.70 USD | +0.018 (+2.7%) | 651,427 | $0.703 | $0.703 | $0.67 | $0.682 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:DARE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.70 | +0.018 | +2.7% | $0.703 | $0.703 | $0.67 | 651,427 | |
| $0.682 | +0.001 | +0.2% | $0.67 | $0.698 | $0.664 | 46,847 | |
| $0.68 | +0.017 | +2.6% | $0.68 | $0.68 | $0.664 | 46,109 | |
| $0.663 | +0.019 | +3.0% | $0.643 | $0.684 | $0.643 | 51,578 | |
| $0.644 | -0.002 | -0.3% | $0.668 | $0.675 | $0.64 | 50,492 | |
| $0.646 | -0.006 | -0.9% | $0.64 | $0.666 | $0.638 | 56,543 | |
| $0.652 | -0.036 | -5.3% | $0.685 | $0.713 | $0.625 | 327,902 | |
| $0.688 | -0.001 | -0.1% | $0.68 | $0.712 | $0.673 | 24,806 | |
| $0.689 | -0.017 | -2.4% | $0.723 | $0.73 | $0.67 | 217,694 | |
| $0.706 | -0.019 | -2.6% | $0.727 | $0.738 | $0.68 | 251,986 | |
| $0.725 | -0.015 | -2.0% | $0.739 | $0.74 | $0.713 | 77,200 | |
| $0.74 | +0.011 | +1.5% | $0.73 | $0.746 | $0.72 | 96,900 | |
| $0.729 | -0.019 | -2.5% | $0.743 | $0.743 | $0.72 | 61,000 | |
| $0.748 | -0.002 | -0.3% | $0.786 | $0.786 | $0.73 | 116,100 | |
| $0.75 | -0.023 | -3.0% | $0.77 | $0.79 | $0.738 | 81,600 | |
| $0.773 | +0.001 | +0.1% | $0.79 | $0.79 | $0.76 | 69,600 | |
| $0.772 | -0.018 | -2.3% | $0.786 | $0.80 | $0.755 | 165,800 | |
| $0.79 | -0.043 | -5.2% | $0.814 | $0.819 | $0.79 | 113,200 | |
| $0.833 | -0.01 | -1.2% | $0.83 | $0.88 | $0.83 | 88,400 | |
| $0.843 | 0.00 | 0.0% | $0.833 | $0.869 | $0.831 | 157,200 | |
| $0.843 | -0.008 | -0.9% | $0.869 | $0.878 | $0.822 | 147,300 | |
| $0.851 | -0.002 | -0.2% | $0.86 | $0.87 | $0.83 | 134,800 | |
| $0.853 | +0.038 | +4.7% | $0.80 | $0.88 | $0.768 | 277,700 | |
| $0.815 | +0.065 | +8.7% | $0.787 | $0.867 | $0.736 | 644,400 | |
| $0.75 | -0.026 | -3.4% | $0.79 | $0.816 | $0.701 | 697,300 | |
| $0.776 | +0.035 | +4.7% | $0.77 | $0.79 | $0.746 | 119,100 | |
| $0.741 | -0.066 | -8.2% | $0.802 | $0.846 | $0.712 | 469,500 | |
| $0.807 | -0.043 | -5.1% | $0.85 | $0.87 | $0.80 | 99,700 | |
| $0.85 | +0.04 | +4.9% | $0.81 | $0.88 | $0.81 | 245,500 | |
| $0.81 | +0.026 | +3.3% | $0.82 | $0.84 | $0.796 | 279,900 | |
| $0.784 | +0.036 | +4.8% | $0.793 | $0.81 | $0.766 | 229,200 | |
| $0.748 | +0.022 | +3.0% | $0.745 | $0.776 | $0.745 | 153,200 | |
| $0.726 | -0.004 | -0.5% | $0.732 | $0.759 | $0.724 | 135,400 | |
| $0.73 | -0.006 | -0.8% | $0.741 | $0.771 | $0.72 | 107,200 | |
| $0.736 | +0.03 | +4.2% | $0.706 | $0.75 | $0.691 | 426,100 | |
| $0.706 | +0.001 | +0.1% | $0.717 | $0.723 | $0.705 | 93,700 | |
| $0.705 | -0.012 | -1.7% | $0.70 | $0.725 | $0.70 | 102,500 | |
| $0.717 | +0.004 | +0.6% | $0.729 | $0.73 | $0.691 | 173,400 | |
| $0.713 | -0.008 | -1.1% | $0.73 | $0.737 | $0.701 | 191,700 | |
| $0.721 | +0.008 | +1.1% | $0.70 | $0.757 | $0.70 | 437,500 | |
| $0.713 | -0.027 | -3.6% | $0.751 | $0.779 | $0.69 | 450,300 | |
| $0.74 | -0.03 | -3.9% | $0.78 | $0.797 | $0.74 | 246,900 | |
| $0.77 | +0.009 | +1.2% | $0.744 | $0.797 | $0.73 | 461,200 | |
| $0.761 | +0.026 | +3.5% | $0.76 | $0.82 | $0.73 | 639,300 | |
| $0.735 | -0.004 | -0.5% | $0.758 | $0.758 | $0.72 | 354,200 | |
| $0.739 | -0.012 | -1.6% | $0.751 | $0.78 | $0.73 | 428,500 | |
| $0.751 | -0.07 | -8.5% | $0.833 | $0.847 | $0.74 | 952,200 | |
| $0.821 | +0.019 | +2.4% | $0.818 | $0.854 | $0.80 | 618,671 | |
| $0.802 | -0.018 | -2.3% | $0.82 | $0.845 | $0.80 | 434,896 | |
| $0.82 | +0.011 | +1.4% | $0.80 | $0.85 | $0.80 | 345,600 | |
| $0.809 | -0.015 | -1.8% | $0.82 | $0.86 | $0.78 | 502,500 | |
| $0.824 | +0.056 | +7.3% | $0.768 | $0.85 | $0.762 | 711,600 | |
| $0.768 | -0.042 | -5.2% | $0.825 | $0.831 | $0.75 | 1,138,100 | |
| $0.81 | -0.12 | -12.9% | $0.929 | $0.93 | $0.81 | 1,950,000 | |
| $0.93 | -0.44 | -32.1% | $1.55 | $1.61 | $0.765 | 8,087,900 | |
| $1.37 | -0.07 | -4.9% | $1.43 | $1.457 | $1.31 | 6,347,000 | |
| $1.44 | 0.00 | 0.0% | $1.45 | $1.468 | $1.415 | 95,000 | |
| $1.44 | +0.08 | +5.9% | $1.38 | $1.455 | $1.38 | 141,900 | |
| $1.36 | -0.04 | -2.9% | $1.40 | $1.41 | $1.35 | 47,400 | |
| $1.40 | +0.07 | +5.3% | $1.36 | $1.42 | $1.36 | 91,700 | |
| $1.33 | -0.01 | -0.7% | $1.305 | $1.38 | $1.305 | 89,900 | |
| $1.34 | 0.00 | 0.0% | $1.32 | $1.38 | $1.30 | 57,300 | |
| $1.34 | +0.06 | +4.7% | $1.29 | $1.38 | $1.29 | 133,800 | |
| $1.28 | +0.06 | +4.9% | $1.23 | $1.34 | $1.23 | 126,400 | |
| $1.22 | -0.02 | -1.6% | $1.24 | $1.27 | $1.21 | 73,300 | |
| $1.24 | +0.08 | +6.9% | $1.18 | $1.24 | $1.13 | 140,500 |
- Ticker
- NASDAQ:DARE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
Latest earnings call · Aug 13, 2026
Dare Bioscience (NASDAQ:DARE) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 1, 2026
Investor Presentation (October 2026)
Investor deck · 40 slides
Calls
Replays
Dare Bioscience (NASDAQ:DARE) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 4:30 PM ET
Watch TranscriptDare Bioscience (NASDAQ:DARE) Q1 2026 Earnings Call
Thu, May 14, 2026 · 4:30 PM ET
Watch TranscriptDare Bioscience (NASDAQ:DARE) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
Oct 30, 2026
Closed $0.70 (+2.7%) on Oct 30, 2026
Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion
Oct 28, 2026
Closed $0.68 (+2.6%) on Oct 28, 2026
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
Oct 26, 2026
Closed $0.644 (-0.3%) on Oct 26, 2026
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
Oct 19, 2026
Closed $0.706 (-2.6%) on Oct 19, 2026
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
Oct 8, 2026
Closed $0.772 (-2.3%) on Oct 8, 2026
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Sep 28, 2026
Closed $0.75 (-3.4%) on Sep 28, 2026
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
Sep 14, 2026
Closed $0.736 (+4.2%) on Sep 14, 2026
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
Sep 11, 2026
Closed $0.706 (+0.1%) on Sep 11, 2026
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
Aug 31, 2026
Closed $0.761 (+3.5%) on Aug 31, 2026
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
Aug 27, 2026
Closed $0.739 (-1.6%) on Aug 27, 2026
Financings
Registered direct offering of common stock (or pre-funded warrants), with concurrent private placement of Series A and Series B warrants
Aug 17, 2026
Announced: US$6M · US$1.37 a share · Warrants at US$1.37 for 60 months · Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Decks
Investor Presentation (October 2026)
Investor deck · 40 slides · Oct 1, 2026
Investor Presentation (July 2026)
Investor deck · 39 slides · Jul 13, 2026
Investor Presentation (June 2026)
Investor deck · 38 slides · Jun 22, 2026
Investor Presentation (April 2026)
Investor deck · 36 slides · Apr 22, 2026
Dare Bioscience, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 181 in all · newest Oct 30, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 13, 2026
- Decks
- 55 decks · latest Oct 1, 2026
Where Dare Bioscience, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DARE · Home listing · This page | NASDAQ | United States | USD |
| BOATS:DARE | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Dare Bioscience, Inc.